Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 12/20 | 0.37 |
| ▸ | HCK | P08631 | 7/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.35 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.35 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.34 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | LYN | P07948 | 1/20 | 0.33 |
| ▸ | FGR | P09769 | 1/20 | 0.33 |
| ▸ | SRC | P12931 | 1/20 | 0.33 |
| ▸ | TEK | Q02763 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6713698 | 0.91 | CPT1A (0.40) | LCKHCKMAPTGRIK1IMPDH2 | |
| SCHEMBL6709959 | 0.89 | LCK (0.38) | LCKHCKMAPTIMPDH2ROCK1 | |
| SCHEMBL6709833 | 0.85 | MAPT (0.42) | MAPTGRIK1GPR35POLBMEN1 | |
| SCHEMBL6711717 | 0.85 | GPR35 (0.38) | LCKHCKMAPTIMPDH2GPR35 | |
| SCHEMBL6708878 | 0.84 | ROCK1 (0.40) | LCKMAPTGRIK1ROCK1GPR35 | |
| SCHEMBL6710340 | 0.83 | ROCK1 (0.39) | LCKGRIK1ROCK1LMNANPSR1 | |
| SCHEMBL6710487 | 0.82 | FTO (0.42) | GRIK1ROCK1LMNAKMT2A | |
| SCHEMBL6710341 | 0.81 | ROCK1 (0.38) | LCKMAPTGRIK1ROCK1NPSR1 | |
| SCHEMBL6708958 | 0.81 | MAPT (0.46) | MAPTGRIK1MEN1KMT2A | |
| SCHEMBL6710127 | 0.81 | ROCK1 (0.47) | LCKGRIK1IMPDH2ROCK1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | GABRD, PHB1, GABBR1 | LCK 4247/4885HCK 3809/4885MAPT 4754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.